Emcure Pharmaceuticals Ltd. IPO

Emcure Pharmaceuticals Limited is a leading Indian pharmaceutical company known for its research and development. They offer a wide range of medications across various therapeutic areas, including gynecology and HIV/AIDS antivirals where they hold the top spot in India. They are rapidly growing with a strong presence in over 70 countries, particularly India, Europe, and Canada. Their focus on chronic illnesses positions them well for future growth in the Indian market.

RHP
View
DRHP
View
Open Date

2024-07-03

Close Date

2024-07-05

IPO Details

Check out the issue details for Emcure Pharmaceuticals Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 1008

Price Band

₹ 960 - 1008

Issue Size

1952.03 Cr.

Issue Type

Book Built

Open

2024-07-03

Close

2024-07-05

Listingprice

₹ 1325.05

ListingGain

31.45%

Listing Date

2024-07-10

CMP

₹ 1308.5

Current Return

29.81%

Company Financials

You can get the following financial statements of Emcure Pharmaceuticals Ltd. as of now.

Subscription Details

The details about the Emcure Pharmaceuticals Limited IPO is as:

  • The issue size of the Emcure Pharmaceuticals Limited IPO is 1952.03 Cr.
  • The price band for Emcure Pharmaceuticals Limited IPO is Rs 960 to Rs 1008.
  • The shares of Emcure Pharmaceuticals Limited IPO will list on 10th July 2024.
  • The latest tentative GMP of Emcure Pharmaceuticals Limited IPO is Rs 295.
  • The shares of Emcure Pharmaceuticals Limited IPO is subscribed 67.85 Times as of 5th July 2024. 

 

Emcure Pharmaceuticals Limited IPO Valuation

The approx valuation of Emcure Pharmaceuticals Limited IPO based on its price band and DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 1008
Existing Shares (Qty) 18.11 Cr
Fresh Issue 800 Cr
Market Cap 19,054.88 Cr
EPS (FY24) Rs 27.54
PE Ratio 36.60x
Industry PE 40.41x

 

Emcure Pharmaceuticals Limited IPO Issue Size

Emcure Pharmaceuticals Limited IPO issue size is 1952.03 Cr

Issue Amount
Fresh Issue 800 Cr
Offer For Sale 1152.03 Cr

 

Emcure Pharmaceuticals Limited IPO Market Lot

An Individual can apply for a minimum 1 lot of 14 shares and a maximum of 14 lots of 196 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 14 14,112
 Maximum 14 196 1,97,568

 

Emcure Pharmaceuticals Limited IPO share offer

The shares of Emcure Pharmaceuticals Limited IPO is subscribed 67.85 Times as of 5th July 2024. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 191.24 Times
Non-Institutional Minimum 15% 49.29 Times
Retail Individual Minimum 35% 7.34 Times
Employee 1,08,900 Shares 8.80 Times
Total   67.85 Times

Allotment Details

Find below the dates for Emcure Pharmaceuticals Limited IPO:

Schedule Date
Basis of Allotment 8 July 2024
Refunds 9 July 2024
Credit to Demat Account 9 July 2024
IPO Listing Date 10 July 2024

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 2375.71 3153.66 3387.24 3107.09 3497.66
Total Expenditure 1952.29 2410.26 2592.57 2668.59 3055.76
Operating Profit 423.42 743.41 794.67 438.49 441.89
Other Income 137.62 111.91 132.68 125.35 138.26
Interest 137.22 123.34 145.14 166.83 166.09
Depreciation 154.97 156.24 165.79 178.52 204.83
Exceptional Items -44.16 -18.29 0 -6.15 -9.32
Profit Before Tax 224.68 557.45 616.42 212.34 199.91
Provision for Tax 49.48 136.97 169.61 52.28 39.08
Net Profit 175.21 420.48 446.81 160.06 160.83
Adjusted EPS (Rs.) 0.97 2.32 2.47 0.89 0.89

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 180.85 180.85 180.85 180.85 181.15
Total Reserves 1733.7 2120.92 1531.68 1661.02 1753.95
Borrowings 453.87 645.97 512.4 600.65 438.21
Other N/C liabilities 123 126.27 164.19 177 253.51
Current liabilities 1379.78 1789.18 1934.06 1996.33 2130.12
Total Liabilities 3871.2 4863.2 4323.18 4615.85 4756.93
Assets
Net Block 1166.06 1277.9 1307.36 1432.71 1718.24
Capital WIP 326.06 192.09 239.25 253.1 106.4
Intangible WIP 0 0 0 0 0
Investments 407.71 863.73 563.36 690.02 684
Loans & Advances 138.23 299.42 63.25 77.51 105.37
Other N/C Assets 25.58 14.6 13.92 23.01 24.91
Current Assets 1807.57 2215.46 2136.05 2139.51 2118.01
Total Assets 3871.2 4863.2 4323.18 4615.85 4756.93
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 224.68 557.45 616.42 212.34 199.91
Adjustment 261.78 246.72 265 309.21 325.56
Changes in Assets & Liabilities -70.5 84.38 -283.04 68.37 126.36
Tax Paid -30.71 -113.67 -170.67 -84.54 -66.86
Operating Cash Flow 385.25 774.87 427.71 505.37 584.97
Investing Cash Flow -168.94 -835.78 -393.81 -270.56 -173.08
Financing Cash Flow -45.87 30.97 -342.96 -54.52 -287.75
Net Cash Flow 170.45 -29.94 -309.06 180.3 124.15
X